Second-generation Ebola vaccines show promise in animal study

April 8, 2015 11:27 PM

10 0

Second-generation Ebola vaccines show promise in animal study

Two candidate Ebola vaccines developed as possible next-generation products fully protected monkeys immunized with a single dose against experimental infection with the strain responsible for West Africa's outbreak, researchers reported today.

The vaccines are intermediate and highly attenuated versions of a vesicular stomatitis virus (VSV) vaccine that contains the Ebola virus glycoprotein. A team from the University of Texas Medical Branch (UTMB) at Galveston and Profectus BioSciences, Inc., reported its findings today in the latest iss...

Read more

To category page

Loading...